Biopharma | May 01, 2026
Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
FTIR and machine learning-based technology enables real-time, cost-effective quantification of food adulterants
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research
Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
A major push to sharpen the future of cancer treatment is underway
Subscribe To Our Newsletter & Stay Updated
